Those risks and uncertainties include, among other things, that the outcomes for each of our ongoing or planned clinical
trials, and in particular the ADVANCE and REALIZE clinical
trials may not be favorable or may not confirm results from earlier clinical trials, that there may be varying interpretations of data produced by one or more of those clinical trials, that enrollment in the ADVANCE or REALIZE clinical trials may be more difficult or slower than we currently anticipate, that unexpecte